Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00125242 · ClinicalTrials.gov registry record · NA

Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis

A NA study of Aphasia and Language Disorders, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT00125242 is a NA study of Aphasia and Language Disorders that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 110 participants, above the 81-participant average among 42 other Aphasia trials with a reported enrollment target (36% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00125242, a NA study of Aphasia and Language Disorders, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

The purpose of this investigation is to further develop and test a treatment for word-finding problems in aphasia. The treatment is designed to strengthen meaning associations within categories of words (e.g., animals, tools, fruits). The treatment is also designed to be used as a search strategy in instances of word-finding difficulty. The study was devised to evaluate the extent to which treatment increases the ability to recall trained, as well as untrained, words.

Interventions

  • BEHAVIORAL Semantic Feature Analysis (SFA)Training

Study Locations (1)

Utah

  • VA Salt Lake City Health Care System, Salt Lake City - Salt Lake City

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2005-07
Est. Completion 2013-04
Phase NA

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00125242

The ClinicalTrials.gov registry entry for NCT00125242 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 81-participant average among 42 other Aphasia trials with a reported enrollment target (36% higher). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Aphasia appearing as the primary indexed condition, and to 1 intervention - of which Semantic Feature Analysis (SFA)Training is the first listed.

NCT00125242 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT00125242 about?

NCT00125242 is a clinical study titled "Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis". The purpose of this investigation is to further develop and test a treatment for word-finding problems in aphasia. The treatment is designed to strengthen meaning associations within categories of words (e.g., animals, tools, fruits). The treatment is also designed to be used as a search strategy in...

What is the current status of trial NCT00125242?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2005-07. Estimated completion is 2013-04.

What conditions does trial NCT00125242 study?

This clinical trial studies the following conditions: Aphasia, Language Disorders, Speech Disorders.

What interventions are being tested in trial NCT00125242?

The interventions under investigation include: Semantic Feature Analysis (SFA)Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT00125242?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00125242 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aphasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.